Bronchodilator for maintenance treatment of bronchospasm associated w/ COPD including chronic bronchitis & emphysema. Concomitant use w/ inhaled β-agonists for acute bronchospasm associated w/ COPD including chronic bronchitis & asthma.
Nebuliser solnAdult including elderly & adolescent >12 yr 40 drops (0.5 mg) tds-qds. Childn 6-12 yr 20 drops (0.25 mg) tds-qds, <6 yr 8-20 drops (0.1-0.25 mg) tds-qds. 250 mcg/2 mL inhalation solnChildn 6-12 yr 1 unit-dose vial; repeated doses can be given until patient is stable, <6 yr Given under medical supervision until patient is stable. 500 mcg/2 mL inhalation solnAdult including elderly & adolescent >12 yr 1 unit-dose vial tds-qds.
Hypersensitivity. Discontinue use if paradoxical bronchospam occurs. Narrow-angle glaucoma; pre-existing urinary outflow tract obstruction eg, prostatic hypertrophy, bladder-neck obstruction; cystic fibrosis. Avoid contact w/ eyes. May affect ability to drive & use machines. Pregnancy & lactation. Nebuliser soln: Asthmatic patients. May cause wheezing & breathing difficulties due to benzalkonium Cl. Not to be used concurrently w/ disodium cromoglycate.
Intensified bronchodilatory effect by β-adrenergics & xanthine prep. Increased risk of acute glaucoma in patients w/ history of narrow-angle glaucoma w/ β-mimetics. Not recommended w/ other anticholinergic drugs.
Manage Account
Change Password
Sign Out
 250 mcg_2 mLada85b3e-5c33-4ede-8ae3-9faa000a2c7d.GIF)
 500 mcg_2 mL91dd9dca-4725-44c6-b675-9faa000a2cad.GIF)
